Literature DB >> 27048538

Region of interest-based versus whole-lung segmentation-based approach for MR lung perfusion quantification in 2-year-old children after congenital diaphragmatic hernia repair.

M Weis1, V Sommer2, F G Zöllner3, C Hagelstein2, K Zahn4, T Schaible5, S O Schoenberg2, K W Neff2.   

Abstract

OBJECTIVE: With a region of interest (ROI)-based approach 2-year-old children after congenital diaphragmatic hernia (CDH) show reduced MR lung perfusion values on the ipsilateral side compared to the contralateral. This study evaluates whether results can be reproduced by segmentation of whole-lung and whether there are differences between the ROI-based and whole-lung measurements.
METHODS: Using dynamic contrast-enhanced (DCE) MRI, pulmonary blood flow (PBF), pulmonary blood volume (PBV) and mean transit time (MTT) were quantified in 30 children after CDH repair. Quantification results of an ROI-based (six cylindrical ROIs generated of five adjacent slices per lung-side) and a whole-lung segmentation approach were compared.
RESULTS: In both approaches PBF and PBV were significantly reduced on the ipsilateral side (p always <0.0001). In ipsilateral lungs, PBF of the ROI-based and the whole-lung segmentation-based approach was equal (p=0.50). In contralateral lungs, the ROI-based approach significantly overestimated PBF in comparison to the whole-lung segmentation approach by approximately 9.5 % (p=0.0013).
CONCLUSIONS: MR lung perfusion in 2-year-old children after CDH is significantly reduced ipsilaterally. In the contralateral lung, the ROI-based approach significantly overestimates perfusion, which can be explained by exclusion of the most ventral parts of the lung. Therefore whole-lung segmentation should be preferred. KEY POINTS: • Ipsilaterally, absolute lung perfusion after CDH is reduced in whole-lung analysis. • Ipsilaterally, the ROI- and whole-lung-based approaches generate identical results. • Contralaterally, the ROI-based approach significantly overestimates perfusion results. • Whole lung should be analysed in MR lung perfusion imaging. • MR lung perfusion measurement is a radiation-free parameter of lung function.

Entities:  

Keywords:  Congenital diaphragmatic hernia; Dynamic contrast-enhanced MRI; Lung perfusion; Lung segmentation; MR perfusion imaging

Mesh:

Substances:

Year:  2016        PMID: 27048538     DOI: 10.1007/s00330-016-4330-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  Quantification of pulmonary blood flow and volume in healthy volunteers by dynamic contrast-enhanced magnetic resonance imaging using a parallel imaging technique.

Authors:  Konstantin Nikolaou; Stefan O Schoenberg; Gunnar Brix; Jeffrey P Goldman; Ulrike Attenberger; Bernd Kuehn; Olaf Dietrich; Maximilian F Reiser
Journal:  Invest Radiol       Date:  2004-09       Impact factor: 6.016

2.  Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging.

Authors:  Christian Fink; Michael Puderbach; Michael Bock; Klaus-Peter Lodemann; Ivan Zuna; Astrid Schmähl; Stefan Delorme; Hans-Ulrich Kauczor
Journal:  Radiology       Date:  2004-04       Impact factor: 11.105

3.  The interdependent contributions of gravitational and structural features to perfusion distribution in a multiscale model of the pulmonary circulation.

Authors:  A R Clark; M H Tawhai; E A Hoffman; K S Burrowes
Journal:  J Appl Physiol (1985)       Date:  2011-02-03

4.  UMMPerfusion: an open source software tool towards quantitative MRI perfusion analysis in clinical routine.

Authors:  Frank G Zöllner; Gerald Weisser; Marcel Reich; Sven Kaiser; Stefan O Schoenberg; Steven P Sourbron; Lothar R Schad
Journal:  J Digit Imaging       Date:  2013-04       Impact factor: 4.056

5.  Effect of inspiratory and expiratory breathhold on pulmonary perfusion: assessment by pulmonary perfusion magnetic resonance imaging.

Authors:  Christian Fink; Sebastian Ley; Frank Risse; Monika Eichinger; Julia Zaporozhan; Ralf Buhmann; Michael Puderbach; Christian Plathow; Hans-Ulrich Kauczor
Journal:  Invest Radiol       Date:  2005-02       Impact factor: 6.016

6.  Congenital diaphragmatic hernia with(out) ECMO: impaired development at 8 years.

Authors:  Marlous J Madderom; Leontien Toussaint; Monique H M van der Cammen-van Zijp; Saskia J Gischler; René M H Wijnen; Dick Tibboel; Hanneke Ijsselstijn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-12-12       Impact factor: 5.747

7.  Lung function over the first 3 years of life in children with congenital diaphragmatic hernia.

Authors:  Howard B Panitch; Daniel J Weiner; Rui Feng; Myrza R Perez; Fiona Healy; Joseph M McDonough; Natalie Rintoul; Holly L Hedrick
Journal:  Pediatr Pulmonol       Date:  2014-07-10

8.  Quantitative pulmonary perfusion imaging at 3.0 T of 2-year-old children after congenital diaphragmatic hernia repair: initial results.

Authors:  F G Zöllner; K Zahn; T Schaible; S O Schoenberg; L R Schad; K W Neff
Journal:  Eur Radiol       Date:  2012-06-13       Impact factor: 5.315

9.  Serial perfusion study depicts pulmonary vascular growth in the survivors of non-extracorporeal membrane oxygenation-treated congenital diaphragmatic hernia.

Authors:  Kamalesh Pal; D K Gupta
Journal:  Neonatology       Date:  2010-04-23       Impact factor: 4.035

10.  Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis.

Authors:  Tobias Heye; Elmar M Merkle; Caecilia S Reiner; Matthew S Davenport; Jeffrey J Horvath; Sebastian Feuerlein; Steven R Breault; Peter Gall; Mustafa R Bashir; Brian M Dale; Atilla P Kiraly; Daniel T Boll
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

View more
  1 in total

1.  The impact of injector-based contrast agent administration in time-resolved MRA.

Authors:  Johannes Budjan; Ulrike I Attenberger; Stefan O Schoenberg; Hubertus Pietsch; Gregor Jost
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.